Ledger.Open graph →
SEC Form D · Amendment · filed June 5, 2014

SignPath Pharma, Inc

Offering
$5.0M
Sold
$4.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
QUAKERTOWN, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (2)

Dan Morrill · Milwaukee, WIExec · DirectorMark Priestaf · Milwaukee, WIExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗